ImmunoGen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.05.17	Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset From ImmunoGen (PR Newswire)
19.05.17	Gainers & Losers Of May 18: ACHN, IMGN, GTHX, ELGX, NLNK... (RTTNews)
16.05.17	Gainers & Losers Of May 15: CBMG, ETRM, ALNY, EGRX, ONCS... (RTTNews)
11.05.17	Technical Reports on Biotech Stocks -- Celsion, Incyte, ImmunoGen, and Catabasis Pharma (PR Newswire)
05.05.17	ImmunoGen Holding On To Strong Gain In Afternoon Trading (RTTNews)
21.04.17	Gainers & Losers Of Apr.20: IMNP, AKTX, IMGN, ALDX, KMPH... (RTTNews)
20.04.17	Gainers & Losers Of Apr.19: SNGX, IMGN, CBLI, SSH, AKTX... (RTTNews)
19.04.17	ImmunoGen Jumps Sharply Following Upgrade By Leerink Partners (RTTNews)
28.02.17	Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS... (RTTNews)
23.02.17	Technical Reports on Biotech Stocks -- Juno Therapeutics, Protalix BioTherapeutics, ImmunoGen, and ContraVir Pharma (PR Newswire)
27.01.17	IMGN Marches Forward, FDA Nod For ZLTQ, Knight Lends Shine To PLX (RTTNews)
09.01.17	Research Reports Initiation on Biotech Stocks -- ImmunoGen, BioMarin Pharma, CEL-SCI, and Dipexium Pharma (PR Newswire)
28.11.16	Research Reports Initiation on Biotech Stocks -- ImmunoGen, Puma Biotech, Arrowhead Pharma, and Intra-Cellular Therapies (PR Newswire)
19.05.16	FDA Greenlights Bladder Cancer Drug, RPRX Up 30% After-hours, Mega Leap For MGNX (RTTNews)
05.02.16	SCLN Settles FCPA Charges, OGXI On Cost Discipline Mode, Shire To Face FDA (RTTNews)
27.01.16	FATE Gets Attention, IMGN Earns Milestone Payment, KIN Gains Weight (RTTNews)
31.07.15	ImmunoGen Q2 Loss Widens - Quick Facts (RTTNews)
30.01.15	ImmunoGen Q2 Profit Results Beat View; Backs 2015 Outlook - Quick Facts (RTTNews)
22.12.14	ImmunoGen Names Richard Gregory As Research And Chief Scientific Officer (RTTNews)
19.12.14	Genentech Announces Top-line Results Of Phase III MARIANNE Trial (RTTNews)
01.08.14	ImmunoGen Q4 Loss Widens; Sees FY15 Revenue Above View - Quick Facts (RTTNews)
31.01.14	ImmunoGen Posts Profit In Q2; Backs FY14 Forecast - Quick Facts (RTTNews)
24.01.14	Earnings Watch For January 24 (HON, KMB, PG, XRX, STT, BMY) (RTTNews)
30.12.13	ImmunoGen Names David Johnston CFO - Update (RTTNews)
30.12.13	ImmunoGen Appoints David Johnston As CFO - Quick Facts (RTTNews)
21.11.13	PETX On The Move, IMGN To Pocket $5Mln, RGLS Gets Richer, MYGN Does It Again (RTTNews)
20.11.13	ImmunoGen Announces Marketing Approval For Kadcyla In EU - Quick Facts (RTTNews)
06.11.13	MYGN, SGEN Boost Outlook, AMRI On A High, ENDP Opens Wallet, IMGN Slammed (RTTNews)
05.11.13	Pre-market Movers For Nov 5 (AOL, CVS, ENDP, KORS, CYTX, GTAT, IMGN, BSFT, OTEX) (RTTNews)
05.11.13	ImmunoGen Decides To Stop IMGN901 Phase II SCLC Study - Quick Facts (RTTNews)
22.10.13	Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda (PR Newswire)
07.10.13	Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen (PR Newswire)
20.09.13	ImmunoGen Reports Positive Decisions For Kadcyla In EU & Japan - Quick Facts (RTTNews)
12.09.13	Critical Alerts For Facebook, HanesBrands, SodaStream, and ImmunoGen Released By InvestorsObserver (PR Newswire)
03.09.13	Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA (PR Newswire)
27.08.13	ImmunoGen CFO Gregory Perry To Resign - Quick Facts (RTTNews)
08.08.13	Critical Alerts For SunPower, Boston Properties, T-Mobile, ImmunoGen, and Santarus Released By InvestorsObserver (PR Newswire)
07.08.13	Collaborations, Global Platforms, and Strong Sales Drive Revenue Growth - Research Report on Baxter, Mylan, ImmunoGen, Emeritus, and Synta (PR Newswire)
05.08.13	CPRX Back Above $1, STEM Grows, TTHI, IMGN On Watch (RTTNews)
02.08.13	Pre-market Movers For August 2 (DELL, TM, EAT, IMGN, MELI, ALSK) (RTTNews)
02.08.13	ImmunoGen Q4 Loss Narrows - Quick Facts (RTTNews)
24.11.09	ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition (Businesswire)
29.10.09	ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results (Businesswire)
17.08.09	ImmunoGen, Inc. Appoints Peter Williams as Vice President, Business Development (Businesswire)
26.11.07	ImmunoGen, Inc. Announces Presentations on Clinical-Stage Compounds at ASH Annual Meeting (Businesswire)
11.07.06	Biotest schliesst Kooperations- und Lizenzvereinbarung mit ImmunoGen (Aktiencheck)
09.02.05	ImmunoGen, Inc. Provides Update on Collaboration with Boehringer Ingel (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite zum Handelsende in Grün
08.02.24		Gewinne in New York: NASDAQ Composite liegt am Nachmittag im Plus
08.02.24		Freundlicher Handel: NASDAQ Composite am Mittag mit positivem Vorzeichen
08.02.24		Gewinne in New York: NASDAQ Composite zum Start des Donnerstagshandels in Grün
30.11.23		Zurückhaltung in New York: NASDAQ Composite zum Ende des Donnerstagshandels mit Abgaben
30.11.23		Handel in New York: NASDAQ Composite gibt am Nachmittag nach
30.11.23		Anleger in New York halten sich zurück: NASDAQ Composite am Mittag schwächer
30.11.23		Zurückhaltung in New York: NASDAQ Composite verliert zum Start des Donnerstagshandels

09.02.24

NASDAQ Composite-Handel aktuell: NASDAQ Composite zum Handelsende in Grün

08.02.24

Gewinne in New York: NASDAQ Composite liegt am Nachmittag im Plus

08.02.24

Freundlicher Handel: NASDAQ Composite am Mittag mit positivem Vorzeichen

08.02.24

Gewinne in New York: NASDAQ Composite zum Start des Donnerstagshandels in Grün

30.11.23

Zurückhaltung in New York: NASDAQ Composite zum Ende des Donnerstagshandels mit Abgaben

30.11.23

Handel in New York: NASDAQ Composite gibt am Nachmittag nach

30.11.23

Anleger in New York halten sich zurück: NASDAQ Composite am Mittag schwächer

30.11.23

Zurückhaltung in New York: NASDAQ Composite verliert zum Start des Donnerstagshandels

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu ImmunoGen Inc.

Aktien Top/Flop

ImmunoGen Peer Group Nachrichten

Meistgelesene Nachrichten